OPTIMIZE Clinical Trial

NMDP OPTIMIZE Clinical Trial

Groundbreaking Trial Seeks to Enhance Blood Cancer Treatment Efficacy and Safety (Minneapolis, MN) —  February 20, 2024 – NMDPSM (formerly known as the National Marrow Donor Program), home to the most diverse blood stem cell and marrow donor registry in the world, announced the enrollment of the first patient in the groundbreaking OPTIMIZE clinical trial today. The trial is sponsored by NMDP through the Center for International Blood and Marrow